SUN Pharmaceutical Industries Limited Sitagliptin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Sitagliptin Export Records India — #12 Exporter, 82 Shipments, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sitagliptin

India Pharmaceutical Trade Intelligence

$75.8M309 Suppliers121 CountriesHS 30049099

ExportsIndia → CANADA11.6%India → MEXICO11.1%

ImportsCANADA → India$43.8K NETHERLANDS → India$23.2K

#1 Buyer: YILMAZ TRANSPORT

SUN Pharmaceutical Industries Limited — Sitagliptin Exporter #12 | $2.0M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Sitagliptin Exporter Profile

Indian Pharmaceutical Exporter · #12 for Sitagliptin · $2.0M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #12 Indian exporter of Sitagliptin with $2.0M in export value and 82 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.7% market share in Sitagliptin exports across 7 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Sitagliptin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Sitagliptin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Sitagliptin?

Country	Value	Shipments	Share
BRAZIL	$1.1M	60	63.8%
BELGIUM	$292.6K	10	17.7%
AUSTRALIA	$190.0K	5	11.5%
CANADA	$44.5K	2	2.7%
MALAYSIA	$43.3K	2

Who Are the Top Buyers of Sitagliptin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
RANBAXY FARMACEUTICA LTDA :	BRAZIL	$383.6K	13
RANBAXY FARMACEUTICA LTDA	BRAZIL	$306.7K	16
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$242.6K	9
RANBAXY FARMACEUTICA LTDA:	BRAZIL	$228.9K	8
SUN PHARMA ANZ PTY LTD.	AUSTRALIA	$190.0K	5
RANBAXY FARMACEUTICA LIMITED	BRAZIL	$96.7K	3
SUN PHARMACEUTICAL INDUSTRIES LIMITED	BELGIUM	$50.0K	1
TARO PHARMACEUTICALS INC.,	CANADA	$44.5K	2
RANBAXY(MALAYSIA)SDN.BHD.	MALAYSIA	$43.3K	2
M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$30.6K	1

SUN Pharmaceutical Industries Limited supplies Sitagliptin to 15 buyers globally. The largest buyer is RANBAXY FARMACEUTICA LTDA : (BRAZIL), followed by RANBAXY FARMACEUTICA LTDA (BRAZIL) and YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sitagliptin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
FOST DE SITAGLIPTINA TAB 100MG 3X10B BREACH CONTAINS: SITAGLIPTINA PHOSPHATE TABLETS PACK : BOX3X10S	$207.1K	6
FOST DE SITAGLIPITINA TAB 100MG 3X10B BREACH CONTAINS: SITAGLIPTINA PHOSPHATE TABLETS. PACK: BOX3X10S	$138.1K	3
FOST DE SITAGLIPTINA TABLETS 50MG (EACHTABLETS CONTAINS: SITAGLIPTIN PHOSPHATE50MG) [39358 PACKS X3X10'S] (BATCH NO. P	$90.2K	3
FOST DE SITAGLIPTINA TABLETS 100MG (EACHTABLETS CONTAINS: SITAGLIPTIN PHOSPHATE100MG) [13800 PACKS X3X10'S] (BATCH NO.	$73.7K	3
FOST DE SITAGLIPTINA TABLETS 50MG (EACHTABLETS CONTAINS: SITAGLIPTIN PHOSPHATETABLETS 50MG) [24080 PACKS X3X10'S] B NO	$55.0K	3
FOST DE SITAGLIPTINA TAB 50MG 3X10B BR EACH CONTAINS: SITAGLIPTINA PHOSPHATE TABLETS PACK : BOX3X10S	$52.1K	2
FOST DE SITAGLIPTINA TABLETS 100MG EACHTABLET CONTAINS: SITAGLIPTINA PHOSPHATETABLETS [10113 PACKS X3X10'S] BATCH NO	$50.0K	1
SITAGLIPTIN TABLETS 100MG 04X07S	$50.0K	1
SITAGLIPTIN SUN TABLETS 50MG, EACH FILMCOATED TABLET CONTAINS: SITAGLIPTIN FUMARATE EQUIVALENT TO 50 MG(PACK :4X7S)	$50.0K	1
FOST DE SITAGLIPTINA TABLETS 100MG (EACHTABLETS CONTAINS: SITAGLIPTINA PHOSPHATE TABLETS 100MG) [8370 PACKS X3X10'S] BA	$50.0K	1

SUN Pharmaceutical Industries Limited exports 50 distinct Sitagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FOST DE SITAGLIPTINA TAB 100MG 3X10B BREACH CONTAINS: SITAGL with 6 shipments worth $207.1K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Sitagliptin Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	FREDUN PHARMACEUTICALS LTD	$2.8M	56	1	$50.0K
11	BETA DRUGS LIMITED	$2.4M	85	1	$28.6K
12	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$2.0M	82	7	$24.7K
10	BAFNA PHARMACEUTICALS LIMITED	$1.3M	26	4	$50.0K
13	DR REDDY S LABORATORIES LTD	$1.3M	26	4	$50.0K

SUN Pharmaceutical Industries Limited ranks #12 among 309 Indian Sitagliptin exporters. Average shipment value of $24.7K compared to the market average of $149.3K. The closest competitors by value are FREDUN PHARMACEUTICALS LTD and BETA DRUGS LIMITED.

Which Indian Ports Ship Sitagliptin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	772	14.4%
DELHI AIR CARGO ACC (INDEL4)	739	13.8%
SAHAR AIR	735	13.7%
DELHI AIR	513	9.6%
NHAVA SHEVA SEA (INNSA1)	217	4.0%
HYDERABAD AIR	213	4.0%
Bombay Air	196	3.7%
HYDERABAD ACC (INHYD4)	191	3.6%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Sitagliptin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 82 individual customs records matching SUN Pharmaceutical Industries Limited exporting Sitagliptin, covering 50 formulations to 7 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 121+ countries, 575+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sitagliptin

Sitagliptin

SUN Pharmaceutical Industries Limited — Sitagliptin Exporter Profile

SUN Pharmaceutical Industries Limited — Sitagliptin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Sitagliptin?

Who Are the Top Buyers of Sitagliptin from SUN Pharmaceutical Industries Limited?

What Is India's Total Sitagliptin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Sitagliptin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Sitagliptin Exporters?

What Sitagliptin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Sitagliptin to Key Markets

Brazil — ANVISA

Australia — TGA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Sitagliptin Exporters?

Which Indian Ports Ship Sitagliptin Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Sitagliptin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sitagliptin Export Data from SUN Pharmaceutical Industries Limited

Sitagliptin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source